Magenta Therapeutics, Inc.

MGTA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$55,984$13,237$10,116$22,792
Short-Term Investments$346,629$244,152$253,114$252,449
Receivables$5,000$39$1,000$0
Inventory$0$0$0$0
Other Curr. Assets$6,212$6,177$6,769$5,663
Total Curr. Assets$413,825$263,605$270,999$280,904
Property Plant & Equip (Net)$1,491$1,585$1,638$1,747
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$152,874$51,705$68,308$81,728
Tax Assets$0$0$0$0
Other NC Assets$9,255$9,181$7,635$9,629
Total NC Assets$163,620$62,471$77,581$93,104
Other Assets$0$0$0$0
Total Assets$577,445$326,076$348,580$374,008
Liabilities
Payables$6,705$5,404$8,269$4,579
Short-Term Debt$217$211$226$320
Tax Payable$0$0$0$0
Deferred Revenue$954$479$479$479
Other Curr. Liab.$15,979$13,999$7,979$13,074
Total Curr. Liab.$23,855$20,093$16,953$18,452
LT Debt$1,068$1,119$1,170$1,171
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,068$1,785$1,851$1,908
Total NC Liab.$7,136$2,904$3,021$3,079
Other Liabilities$0$0$0$0
Cap. Leases$1,285$1,330$1,396$1,491
Total Liabilities$30,991$22,997$19,974$21,531
Equity
Pref Stock$0$0$0$0
Common Stock$43$32$32$31
Retained Earnings-$272,297-$235,532-$203,903-$174,392
AOCI$163$98$270$106
Other Equity$818,545$538,481$532,207$526,732
Total Equity$546,454$303,079$328,606$352,477
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$577,445$326,076$348,580$374,008
Net Debt-$54,699-$11,907-$8,720-$21,301
Magenta Therapeutics, Inc. (MGTA) Financial Statements & Key Stats | AlphaPilot